Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
strontium chloride Sr 89
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Trial of Strontium-89 vs Palliative Local Radiotherapy in Patients with Hormone-Refractory Prostate Cancer with Painful Osseous Metastases (Summary Last Modified 03/2001)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
any age
Sponsor:
Protocol IDs:
EORTC-30921
, NCT00002503
2.
Phase I/II Study of Strontium-89 in the Treatment of Patients with Endocrine-Resistant Prostate Cancer with Painful Osseous Metastases
Phase:
Phase II, Phase I
Type:
Supportive care, Treatment
Status:
Completed
Age:
any age
Sponsor:
NCI
Protocol IDs:
RTOG-8821
, RTOG-88-21
3.
Phase II Randomized Study of Strontium-89 Alone, Estramustine/Vinblastine, and Strontium-89 plus Estramustine/Vinblastine in Androgen-Independent Prostate Cancer Metastatic to Bone (Summary Last Modified 02/1999)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MSKCC-95094
, NCI-V96-0831
4.
Phase II Study of Sn-117m DTPA versus Strontium-89 in Patients with Painful Bone Metastases Secondary to Prostate Cancer (Summary Last Modified 08/1999)
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
DIATIDE-117-30
, UCMC-97012201
5.
Phase II Randomized Study of Doxorubicin and Strontium Chloride Sr 89 With or Without Celecoxib in Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
Any age
Sponsor:
NCI
Protocol IDs:
MDA-ID-02035
, NCT00080782
6.
Phase II Randomized Study of Hormonal Ablative Therapy, Doxorubicin, and Zoledronate With or Without Strontium Chloride Sr 89 in Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
MDA-2003-0922
, 6459, NCI-6459, NCT00081159
7.
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
GUPPS2
, NCT00156884
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute